Clinical Trial Update: Evaluating Treatment Strategies for p53 Mutant Oral Cancer and Oral Cancer Precursors [NA]

View source ↗

Summary

A University of British Columbia study is evaluating treatment strategies for p53-mutant oral cancer and its precursors, with no recruitment yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Epithelial Dysplasia
• Oral Squamous Cell Carcinoma

Snippet

Sponsor: University of British Columbia | Conditions: Oral Epithelial Dysplasia (OED), Oral Squamous Cell Carcinoma (SCC) | NA | Status: NOT_YET_RECRUITING